• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌细胞核和细胞质中的 CD43 是一个潜在的治疗靶点。

CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target.

机构信息

Department of Hematology/Oncology, Gundersen Medical Foundation, La Crosse, WI 54601, USA.

出版信息

Int J Cancer. 2013 Apr 15;132(8):1761-70. doi: 10.1002/ijc.27873. Epub 2012 Oct 29.

DOI:10.1002/ijc.27873
PMID:23015282
Abstract

CD43 is a transmembrane sialoglycoprotein. Normally the molecule is only produced by white blood cells where it regulates functions such as intercellular adhesion, intracellular signaling, apoptosis, migration and proliferation. Two CD43 antibodies were used to interrogate 66 cases of non-small cell lung cancer (NSCLC) and 24 cases of small cell lung cancer (SCLC). In addition, we engineered the CD43-positive lung cancer cell line A549 to stably express either non-targeted or CD43-targeted small-interfering RNA (siRNA). These lines were then subjected to in vitro assays of apoptosis, natural killer (NK) cell cytotoxicity, intercellular adhesion and transendothelial migration. A xenograft mouse model evaluated the ability of the lines to grow primary tumors in vivo. CD43 was found to be expressed in the majority of both SCLC and NSCLC. Inclusive of CD43-negative tumors, differential patterns of nuclear and cytoplasmic expression of CD43 define four molecular subcategories of lung cancer. Targeting CD43 in A549 lung cancer cells, increased homotypic adhesion, decreased heterotypic adhesion and transendothelial migration, increased susceptibility to apoptosis and increased vulnerability to lysis by NK cells. Furthermore, targeting inhibited the growth of primary tumors in nude mice.

摘要

CD43 是一种跨膜唾液酸糖蛋白。正常情况下,该分子仅由白细胞产生,在白细胞中它调节细胞间黏附、细胞内信号转导、细胞凋亡、迁移和增殖等功能。我们使用两种 CD43 抗体检测了 66 例非小细胞肺癌(NSCLC)和 24 例小细胞肺癌(SCLC)。此外,我们将 CD43 阳性肺癌细胞系 A549 进行基因工程改造,使其稳定表达非靶向或 CD43 靶向的小干扰 RNA(siRNA)。然后对这些细胞系进行体外细胞凋亡、自然杀伤(NK)细胞细胞毒性、细胞间黏附和跨内皮迁移的检测。在异种移植小鼠模型中评估这些细胞系在体内形成原发性肿瘤的能力。我们发现 CD43 在大多数 SCLC 和 NSCLC 中均有表达。包括 CD43 阴性肿瘤在内,CD43 的核和细胞质表达的差异模式定义了肺癌的四个分子亚型。在 A549 肺癌细胞中靶向 CD43,可增加同质黏附、减少异质黏附和跨内皮迁移,增加对细胞凋亡的敏感性,并增加对 NK 细胞裂解的易感性。此外,靶向治疗抑制了裸鼠原发性肿瘤的生长。

相似文献

1
CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target.肺癌细胞核和细胞质中的 CD43 是一个潜在的治疗靶点。
Int J Cancer. 2013 Apr 15;132(8):1761-70. doi: 10.1002/ijc.27873. Epub 2012 Oct 29.
2
Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy.唾液酸糖蛋白表达的细胞内模式定义了乳腺癌的一种新的分子分类,并代表了治疗的新靶点。
Br J Cancer. 2014 Jan 7;110(1):146-55. doi: 10.1038/bjc.2013.526. Epub 2013 Nov 26.
3
5-Fluorouracil and interleukin-2 immunochemotherapy enhances immunogenicity of non-small cell lung cancer A549 cells through upregulation of NKG2D ligands.5-氟尿嘧啶与白细胞介素-2免疫化疗通过上调NKG2D配体增强非小细胞肺癌A549细胞的免疫原性。
Asian Pac J Cancer Prev. 2014;15(9):4039-44. doi: 10.7314/apjcp.2014.15.9.4039.
4
Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein.基于质谱的肿瘤抗原 UN1 鉴定为跨膜 CD43 唾液酸化糖蛋白。
Mol Cell Proteomics. 2011 May;10(5):M111.007898. doi: 10.1074/mcp.M111.007898. Epub 2011 Mar 3.
5
Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.PKM2 的亚细胞区室化鉴定了体外和体内人类非小细胞肺癌小鼠模型的抗 PKM2 治疗反应。
PLoS One. 2019 May 23;14(5):e0217131. doi: 10.1371/journal.pone.0217131. eCollection 2019.
6
ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells.肺癌细胞系中细胞间黏附分子-1(ICAM-1)的表达:细胞因子上调其表达对与淋巴因子激活的杀伤细胞(LAK细胞)相互作用的影响
Eur Respir J. 1996 Sep;9(9):1831-8. doi: 10.1183/09031936.96.09091831.
7
CD43 diminishes susceptibility to T lymphocyte-mediated cytolysis.CD43降低了对T淋巴细胞介导的细胞溶解的敏感性。
J Immunol. 1995 Feb 1;154(3):1097-104.
8
[shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].[短发夹RNA介导的胰岛素样生长因子I受体基因沉默抑制非小细胞肺癌细胞增殖、诱导细胞凋亡并抑制肿瘤生长:体内外实验]
Zhonghua Yi Xue Za Zhi. 2007 Jun 5;87(21):1506-9.
9
Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy.长链非编码 RNA MALAT1 通过调控自噬对人非小细胞肺癌 A549 细胞增殖和凋亡及体内移植瘤生长的影响
Cancer Biomark. 2018;22(1):63-72. doi: 10.3233/CBM-170917.
10
Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer.热休克蛋白 70 激活的自然杀伤细胞与 PD-1 抑制联合应用显著提高胶质母细胞瘤和肺癌的临床前模型的总生存率。
Front Immunol. 2019 Mar 22;10:454. doi: 10.3389/fimmu.2019.00454. eCollection 2019.

引用本文的文献

1
Abnormal expression of LCA and CD43 in SCLC: a rare case report and brief literature review.小细胞肺癌中LCA和CD43的异常表达:一例罕见病例报告及文献简要综述
BMC Pulm Med. 2024 Apr 22;24(1):195. doi: 10.1186/s12890-024-03005-w.
2
Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer.靶向 CD43 通过重新激活结直肠癌中的抗肿瘤免疫应答来优化癌症免疫治疗。
Cell Oncol (Dordr). 2023 Jun;46(3):777-791. doi: 10.1007/s13402-023-00794-w. Epub 2023 Mar 15.
3
Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
BCCIP 的过表达预示着不良的预后,并促进肺腺癌的增殖和迁移。
Thorac Cancer. 2021 Sep;12(17):2324-2338. doi: 10.1111/1759-7714.14073. Epub 2021 Jul 23.
4
Targeting E-selectin to Tackle Cancer Using Uproleselan.使用乌罗司他单抗靶向E-选择素治疗癌症
Cancers (Basel). 2021 Jan 18;13(2):335. doi: 10.3390/cancers13020335.
5
Decreased expression of EFCC1 and its prognostic value in lung adenocarcinoma.EFCC1在肺腺癌中的表达降低及其预后价值
Ann Transl Med. 2019 Nov;7(22):672. doi: 10.21037/atm.2019.10.41.
6
Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment.丙酮酸激酶M2:重塑肿瘤微环境中的代谢缺陷
Cancer Microenviron. 2019 Dec;12(2-3):149-167. doi: 10.1007/s12307-019-00226-0. Epub 2019 Jun 10.
7
An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes.CD43信号转导的另一种模式激活T淋巴细胞的促生存途径。
Immunology. 2017 Jan;150(1):87-99. doi: 10.1111/imm.12670. Epub 2016 Oct 12.
8
Suppression of Rituximab-resistant B-cell lymphoma with a novel multi-component anti-CD20 mAb nanocluster.用新型多组分抗CD20单克隆抗体纳米簇抑制利妥昔单抗耐药的B细胞淋巴瘤
Oncotarget. 2015 Sep 15;6(27):24192-204. doi: 10.18632/oncotarget.4206.
9
Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity.具有卓越淋巴瘤抑制活性的抗CD20单克隆抗体纳米组合的构建与表征
Int J Nanomedicine. 2015 Jul 30;10:4783-96. doi: 10.2147/IJN.S80129. eCollection 2015.
10
Common polymorphisms in the CD43 gene region are associated with tuberculosis disease and mortality.CD43基因区域的常见多态性与结核病及死亡率相关。
Am J Respir Cell Mol Biol. 2015 Mar;52(3):342-8. doi: 10.1165/rcmb.2014-0114OC.